{
  "report_rows": [
    {
      "kpi": "Revenue (FQ4'26)",
      "prediction": "BEAT",
      "answer": "pred ~$3.65B vs. cons $3.49B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS (FQ4'26)",
      "prediction": "BEAT",
      "answer": "pred ~$5.35 vs. cons $5.10",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP Gross Margin (FQ4'26)",
      "prediction": "BEAT",
      "answer": "pred ~48.7% vs. cons ~47.3%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue guide (FQ1'27)",
      "prediction": "BETTER",
      "answer": "guide ~$3.75B vs. cons ~$3.65B (FQ1 2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS guide (FQ1'27)",
      "prediction": "BETTER",
      "answer": "guide ~$5.45 vs. cons ~$5.20 (FQ1 2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Multi-year revenue growth target commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~20%+ CAGR reiterated vs. cons ~20% CAGR baked in (multi-year FY27-FY29 framework)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 6.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 8.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Consensus already sits above STX's own guide, so a clean beat-and-raise (5th straight quarter) plus reiterated/raised FY27 growth framework and nearline capacity booked into 2027 should trigger a wave of price-target hikes (Citi/Wells/Wedbush already primed at $1,000-1,240) rather than an immediate fade; the pre-print 25% pullback already de-risked some of the 'priced for perfection' setup, reducing sell-the-news dynamics. Residual could still be capped versus day-1 pop as high-multiple positioning and any softness in incremental gross-margin commentary or HAMR yield/ramp details prompt partial give-back, so follow-through is moderate rather than explosive.",
  "day5_confidence": "LOW"
}